Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: oral etoposide + anlotinib
Sponsor: Chinese Academy of Medical Sciences